173 related articles for article (PubMed ID: 33130707)
1. [In Situ Ductal Carcinoma with Hereditary Breast and Ovarian Cancer Syndrome in a Patient Who Received Contralateral Risk-Reducing Mastectomy-A Case Report].
Kosaka Y; Kikuchi M; Nishimiya H; Katoh H; Kawaguchi R; Araki N; Shimazu M; Tsumura H; Waraya M; Takada F; Sengoku N; Sangai T
Gan To Kagaku Ryoho; 2020 Sep; 47(9):1387-1389. PubMed ID: 33130707
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
Murthy V; Chamberlain RS
Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
[TBL] [Abstract][Full Text] [Related]
3. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
[TBL] [Abstract][Full Text] [Related]
4. [Case of Spindle Cell Carcinoma of the Breast Resistant Neoadjuvant Chemotherapy].
Tanaka A; Nakayama H; Ono Y; Nukada S; Amano S; Katayama Y; Osaragi T; Tani K; Masuda M
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2041-2043. PubMed ID: 33468794
[TBL] [Abstract][Full Text] [Related]
5. [Hereditary Breast and Ovarian Cancer(HBOC)in a Young Adult-A Case Report].
Adachi K; Kubota H; Suzuki S; Hirano T; Ishibashi N; Sakurai K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1843-1845. PubMed ID: 35046349
[TBL] [Abstract][Full Text] [Related]
6. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
8. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
9. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
[TBL] [Abstract][Full Text] [Related]
10. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
[TBL] [Abstract][Full Text] [Related]
11. Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
Yoshimura A; Okumura S; Sawaki M; Hattori M; Ishiguro J; Adachi Y; Kotani H; Gondo N; Kataoka A; Iwase M; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Takaiso N; Hyodo I; Iwata H
Breast Cancer; 2018 Sep; 25(5):539-546. PubMed ID: 29520501
[TBL] [Abstract][Full Text] [Related]
12. A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan.
Inuzuka M; Watanabe C; Yokoyama S; Kuwayama T; Akashi-Tanaka S; Arai M; Nakamura S;
Clin Breast Cancer; 2021 Feb; 21(1):e48-e52. PubMed ID: 32928640
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
[TBL] [Abstract][Full Text] [Related]
14. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.
Hoogerbrugge N; Bult P; de Widt-Levert LM; Beex LV; Kiemeney LA; Ligtenberg MJ; Massuger LF; Boetes C; Manders P; Brunner HG
J Clin Oncol; 2003 Jan; 21(1):41-5. PubMed ID: 12506168
[TBL] [Abstract][Full Text] [Related]
16. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
[TBL] [Abstract][Full Text] [Related]
17. A case of simultaneous breast cancer and ovarian cancer based on a hereditary breast and ovarian cancer syndrome.
Kotaka S; Yasui H; Tsubouchi H; Mori M; Kotani H; Yoshimura A; Ouchi A; Okuno M; Komori K; Shimizu Y; Suzuki S
Nagoya J Med Sci; 2023 Nov; 85(4):814-821. PubMed ID: 38155625
[TBL] [Abstract][Full Text] [Related]
18. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
Kiely BE; Jenkins MA; McKinley JM; Friedlander ML; Weideman P; Milne RL; McLachlan SA; Hopper JL; Phillips KA
Breast Cancer Res Treat; 2010 Apr; 120(3):715-23. PubMed ID: 19669874
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?
Reynolds C; Davidson JA; Lindor NM; Glazebrook KN; Jakub JW; Degnim AC; Sandhu NP; Walsh MF; Hartmann LC; Boughey JC
Ann Surg Oncol; 2011 Oct; 18(11):3102-9. PubMed ID: 21947588
[TBL] [Abstract][Full Text] [Related]
20. Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance.
Manning AT; Wood C; Eaton A; Stempel M; Capko D; Pusic A; Morrow M; Sacchini V
Br J Surg; 2015 Oct; 102(11):1354-9. PubMed ID: 26313374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
